$NYMX News Sapient surges on Publicis buyout:
Post# of 94265
Posted On: 11/03/2014 1:27:19 PM
$NYMX News
Sapient surges on Publicis buyout: Big U.S. stock movers 9:11 a.m. Today - MarketWatch
Friday’s biggest advancers & decliners 5:40 p.m. Dec. 17, 2010 - Kate Gibson
Seven technically strong stocks to buy on a dip 11:15 a.m. May 2, 2007 - Harry Boxer
Nymox: NX-1207 drug has attracted 'serious' interest 1:39 p.m. Jan. 31, 2007 - Gabriel Madway
Nymox: NX-1207 drug has attracted 'serious' interest 1:35 p.m. Jan. 31, 2007 - Gabriel Madway
Tuesday's biggest stock gainers and decliners 6:30 p.m. Dec. 12, 2006 - MarketWatch
Nymox: Review of NX-1207 trial shows no serious side effects 10:09 a.m. June 27, 2006 - Gabriel Madway
Nymox shares up 4.6% at $2.72 10:01 a.m. June 27, 2006 - Gabriel Madway
Nymox: NX-1207 is treatment for benign prostatic hyperplasia 10:00 a.m. June 27, 2006 - Gabriel Madway
Nymox: All trial subjects have completed dosing 9:56 a.m. June 27, 2006 - Gabriel Madway
Nymox: Review of NX-1207 trial shows no serious side effects 9:55 a.m. June 27, 2006 - Gabriel Madway
Nymox Pharma: Positive results on AlzheimAlert from studies 12:42 p.m. June 15, 2006 - Katherine Hunt
Nymox shares down 4.2% at $2.72 12:25 p.m. June 15, 2006 - Gabriel Madway
Nymox reports positive results from AlzheimAlert studies 12:25 p.m. June 15, 2006 - Gabriel Madway
Nymox inks new contract for Alzheimer's test in Korea 11:49 a.m. June 14, 2006 - Katherine Hunt
Nymox shares up 3c at $2.82 11:43 a.m. June 14, 2006 - Katherine Hunt
Terms of Nymox contract with Kyung Min Meditech undisclosed 11:42 a.m. June 14, 2006 - Katherine Hunt
Nymox inks new contract with Kyung Min Meditech in Korea 11:42 a.m. June 14, 2006 - Katherine Hunt
Nymox inks new contract for Alzheimer's test in Korea 11:41 a.m. June 14, 2006 - Katherine Hunt
Nymox Pharma NX-1207 Phase II trial patient dosing complete 8:53 a.m. June 9, 2006 - Carolyn Pritchard
Ad Comm smacks down Sonacare's HIFU device for prostate cancer 12:53 p.m. Oct. 3, 2014 - Seeking Alpha
Encouraging trial results for Nymox prostate cancer drug candidate 12:37 p.m. Sept. 10, 2014 - Seeking Alpha
Encouraging interim results for BPH drug 1:13 p.m. July 22, 2014 - Seeking Alpha
Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox 6:51 a.m. July 18, 2014 - TheStreet.com
Enrollment complete in second BPH Phase 3 trial 10:29 a.m. July 15, 2014 - Seeking Alpha
Oversold Conditions For Nymox Pharmaceutical (NYMX) 12:05 p.m. April 30, 2014 - TheStreet.com
The good, the bad and the ugly about Nymox's cancer drug trial 10:32 a.m. April 30, 2014 - Seeking Alpha
4 Biotechnology Stocks to Sell Now 4:30 a.m. Jan. 29, 2014 - InvestorPlace.com
Is Nymox The Next Unknown Biotech Turned High Flyer? 3:39 p.m. July 15, 2013 - Seeking Alpha
In Nymox The Next Unknown Biotech Turned High Flyer? 3:39 p.m. July 15, 2013 - Seeking Alpha
Nymox Pharma: Developing A Potential Long-Term Treatment For BPH 3:43 p.m. April 3, 2013 - Seeking Alpha
Good News for Nymox's Pipeline - Analyst Blog 5:25 p.m. March 21, 2013 - Zacks.com
4 Healthcare Stock Stories for Tuesday Investment Wellness 2:54 p.m. March 19, 2013 - Wall St. Cheat Sheet
Market Close: Big Winners & Losers for March 18, 2013 (CHRY, ATOS, NYMX, PRWT, ULTR, AMBO, EFUT, CNET, PTX, LDK) 2:20 p.m. March 18, 2013 - 247WallSt.com
4 Healthcare Stock Stories to Spark Investment Chatter 7:33 p.m. March 5, 2013 - Wall St. Cheat Sheet
Nymox Tries for Recovery on Safety Profile of NX-1207 for Prostate Cancer 11:02 a.m. March 5, 2013 - 247WallSt.com
11 Must Read Weekend Stock Stories For Monday 11:55 a.m. March 2, 2013 - 247WallSt.com
Hot Stocks: Ten Super Crazy Volume Spikes 1:08 p.m. March 1, 2013 - 247WallSt.com
4 Healthcare Stock Stories for Tuesday Wellness 3:45 p.m. Feb. 19, 2013 - Wall St. Cheat Sheet
8 Biotechnology Stocks to Sell Now 4:00 a.m. Jan. 16, 2013 - InvestorPlace.com
Nymox NX-1207 BPH Pivotal Phase 3 U.S. Studies NX02-0017 and NX02-0018 Fail to Meet Primary Efficacy Endpoints 12:01 p.m. Nov. 2, 2014 - GlobeNewswire
Nymox Announces Positive Prostate Cancer 8 Month Clinical Trial Results 8:31 a.m. Sept. 10, 2014 - GlobeNewswire
Nymox Reports Second Quarter 2014 Financial Results 8:31 a.m. Aug. 11, 2014 - GlobeNewswire
Press Release Issued Under the Early Warning System/Sale of Shares of Nymox Pharmaceutical Corporation 4:01 p.m. Aug. 6, 2014 - GlobeNewswire
Nymox Announces Positive Efficacy Results in Phase 3 Repeat Injection Trial of NX-1207 for BPH 8:30 a.m. July 22, 2014 - GlobeNewswire
Nymox Announces Completion of Enrollment for Second BPH Re-Injection Study 8:30 a.m. July 15, 2014 - GlobeNewswire
Nymox Reports Positive Update on Nerve Sparing and Sexual Function Preservation in Men Treated With NX-1207 9:01 a.m. June 17, 2014 - GlobeNewswire
Nymox Reports Positive New Safety Study Data for Phase 3 BPH Drug 9:16 a.m. June 11, 2014 - GlobeNewswire
Nymox Reports New Results on Favorable Side Effect Profile of NX-1207 Treatment 8:51 a.m. May 21, 2014 - GlobeNewswire
Nymox Reports First Quarter 2014 Financial Results 8:46 a.m. May 15, 2014 - GlobeNewswire
Nymox Pharmaceutical Late- Stage Clinical Trials Substantiating Investor Interest; Analyst Report by BrokerBank Securities, Inc. 6:00 a.m. May 14, 2014 - PR Newswire - PRF
Nymox Reports Positive Results Showing That NX-1207 Treatment for Prostate Cancer Does Not Affect Testosterone Levels 8:46 a.m. May 13, 2014 - GlobeNewswire
Nymox Announces Completion of Second Pivotal Phase 3 NX-1207 Trial for BPH 9:31 a.m. May 8, 2014 - GlobeNewswire
Nymox Announces Positive New Prostate Cancer Clinical Trial Results 9:01 a.m. May 6, 2014 - GlobeNewswire
Nymox Reports Top-Line Results for Localized Prostate Cancer Study 8:32 a.m. April 30, 2014 - GlobeNewswire
Nymox Reports 2013 Financial Results 12:00 p.m. March 14, 2014 - GlobeNewswire
Nymox Announces Appointment of Andre Monette 2:00 p.m. Feb. 5, 2014 - GlobeNewswire
Nymox Provides Update on NX-1207 Phase 3 BPH and Phase 2 Prostate Cancer Clinical Trial Activities 11:30 a.m. Jan. 28, 2014 - GlobeNewswire
Nymox Closes Recruitment for NX-1207 Phase 2 Prostate Cancer Trial 10:00 a.m. Jan. 13, 2014 - GlobeNewswire
Madison Capital Corporation Announces Proposed Qualifying Transaction 12:36 p.m. Nov. 21, 2013 - Marketwire
Sapient surges on Publicis buyout: Big U.S. stock movers 9:11 a.m. Today - MarketWatch
Friday’s biggest advancers & decliners 5:40 p.m. Dec. 17, 2010 - Kate Gibson
Seven technically strong stocks to buy on a dip 11:15 a.m. May 2, 2007 - Harry Boxer
Nymox: NX-1207 drug has attracted 'serious' interest 1:39 p.m. Jan. 31, 2007 - Gabriel Madway
Nymox: NX-1207 drug has attracted 'serious' interest 1:35 p.m. Jan. 31, 2007 - Gabriel Madway
Tuesday's biggest stock gainers and decliners 6:30 p.m. Dec. 12, 2006 - MarketWatch
Nymox: Review of NX-1207 trial shows no serious side effects 10:09 a.m. June 27, 2006 - Gabriel Madway
Nymox shares up 4.6% at $2.72 10:01 a.m. June 27, 2006 - Gabriel Madway
Nymox: NX-1207 is treatment for benign prostatic hyperplasia 10:00 a.m. June 27, 2006 - Gabriel Madway
Nymox: All trial subjects have completed dosing 9:56 a.m. June 27, 2006 - Gabriel Madway
Nymox: Review of NX-1207 trial shows no serious side effects 9:55 a.m. June 27, 2006 - Gabriel Madway
Nymox Pharma: Positive results on AlzheimAlert from studies 12:42 p.m. June 15, 2006 - Katherine Hunt
Nymox shares down 4.2% at $2.72 12:25 p.m. June 15, 2006 - Gabriel Madway
Nymox reports positive results from AlzheimAlert studies 12:25 p.m. June 15, 2006 - Gabriel Madway
Nymox inks new contract for Alzheimer's test in Korea 11:49 a.m. June 14, 2006 - Katherine Hunt
Nymox shares up 3c at $2.82 11:43 a.m. June 14, 2006 - Katherine Hunt
Terms of Nymox contract with Kyung Min Meditech undisclosed 11:42 a.m. June 14, 2006 - Katherine Hunt
Nymox inks new contract with Kyung Min Meditech in Korea 11:42 a.m. June 14, 2006 - Katherine Hunt
Nymox inks new contract for Alzheimer's test in Korea 11:41 a.m. June 14, 2006 - Katherine Hunt
Nymox Pharma NX-1207 Phase II trial patient dosing complete 8:53 a.m. June 9, 2006 - Carolyn Pritchard
Ad Comm smacks down Sonacare's HIFU device for prostate cancer 12:53 p.m. Oct. 3, 2014 - Seeking Alpha
Encouraging trial results for Nymox prostate cancer drug candidate 12:37 p.m. Sept. 10, 2014 - Seeking Alpha
Encouraging interim results for BPH drug 1:13 p.m. July 22, 2014 - Seeking Alpha
Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox 6:51 a.m. July 18, 2014 - TheStreet.com
Enrollment complete in second BPH Phase 3 trial 10:29 a.m. July 15, 2014 - Seeking Alpha
Oversold Conditions For Nymox Pharmaceutical (NYMX) 12:05 p.m. April 30, 2014 - TheStreet.com
The good, the bad and the ugly about Nymox's cancer drug trial 10:32 a.m. April 30, 2014 - Seeking Alpha
4 Biotechnology Stocks to Sell Now 4:30 a.m. Jan. 29, 2014 - InvestorPlace.com
Is Nymox The Next Unknown Biotech Turned High Flyer? 3:39 p.m. July 15, 2013 - Seeking Alpha
In Nymox The Next Unknown Biotech Turned High Flyer? 3:39 p.m. July 15, 2013 - Seeking Alpha
Nymox Pharma: Developing A Potential Long-Term Treatment For BPH 3:43 p.m. April 3, 2013 - Seeking Alpha
Good News for Nymox's Pipeline - Analyst Blog 5:25 p.m. March 21, 2013 - Zacks.com
4 Healthcare Stock Stories for Tuesday Investment Wellness 2:54 p.m. March 19, 2013 - Wall St. Cheat Sheet
Market Close: Big Winners & Losers for March 18, 2013 (CHRY, ATOS, NYMX, PRWT, ULTR, AMBO, EFUT, CNET, PTX, LDK) 2:20 p.m. March 18, 2013 - 247WallSt.com
4 Healthcare Stock Stories to Spark Investment Chatter 7:33 p.m. March 5, 2013 - Wall St. Cheat Sheet
Nymox Tries for Recovery on Safety Profile of NX-1207 for Prostate Cancer 11:02 a.m. March 5, 2013 - 247WallSt.com
11 Must Read Weekend Stock Stories For Monday 11:55 a.m. March 2, 2013 - 247WallSt.com
Hot Stocks: Ten Super Crazy Volume Spikes 1:08 p.m. March 1, 2013 - 247WallSt.com
4 Healthcare Stock Stories for Tuesday Wellness 3:45 p.m. Feb. 19, 2013 - Wall St. Cheat Sheet
8 Biotechnology Stocks to Sell Now 4:00 a.m. Jan. 16, 2013 - InvestorPlace.com
Nymox NX-1207 BPH Pivotal Phase 3 U.S. Studies NX02-0017 and NX02-0018 Fail to Meet Primary Efficacy Endpoints 12:01 p.m. Nov. 2, 2014 - GlobeNewswire
Nymox Announces Positive Prostate Cancer 8 Month Clinical Trial Results 8:31 a.m. Sept. 10, 2014 - GlobeNewswire
Nymox Reports Second Quarter 2014 Financial Results 8:31 a.m. Aug. 11, 2014 - GlobeNewswire
Press Release Issued Under the Early Warning System/Sale of Shares of Nymox Pharmaceutical Corporation 4:01 p.m. Aug. 6, 2014 - GlobeNewswire
Nymox Announces Positive Efficacy Results in Phase 3 Repeat Injection Trial of NX-1207 for BPH 8:30 a.m. July 22, 2014 - GlobeNewswire
Nymox Announces Completion of Enrollment for Second BPH Re-Injection Study 8:30 a.m. July 15, 2014 - GlobeNewswire
Nymox Reports Positive Update on Nerve Sparing and Sexual Function Preservation in Men Treated With NX-1207 9:01 a.m. June 17, 2014 - GlobeNewswire
Nymox Reports Positive New Safety Study Data for Phase 3 BPH Drug 9:16 a.m. June 11, 2014 - GlobeNewswire
Nymox Reports New Results on Favorable Side Effect Profile of NX-1207 Treatment 8:51 a.m. May 21, 2014 - GlobeNewswire
Nymox Reports First Quarter 2014 Financial Results 8:46 a.m. May 15, 2014 - GlobeNewswire
Nymox Pharmaceutical Late- Stage Clinical Trials Substantiating Investor Interest; Analyst Report by BrokerBank Securities, Inc. 6:00 a.m. May 14, 2014 - PR Newswire - PRF
Nymox Reports Positive Results Showing That NX-1207 Treatment for Prostate Cancer Does Not Affect Testosterone Levels 8:46 a.m. May 13, 2014 - GlobeNewswire
Nymox Announces Completion of Second Pivotal Phase 3 NX-1207 Trial for BPH 9:31 a.m. May 8, 2014 - GlobeNewswire
Nymox Announces Positive New Prostate Cancer Clinical Trial Results 9:01 a.m. May 6, 2014 - GlobeNewswire
Nymox Reports Top-Line Results for Localized Prostate Cancer Study 8:32 a.m. April 30, 2014 - GlobeNewswire
Nymox Reports 2013 Financial Results 12:00 p.m. March 14, 2014 - GlobeNewswire
Nymox Announces Appointment of Andre Monette 2:00 p.m. Feb. 5, 2014 - GlobeNewswire
Nymox Provides Update on NX-1207 Phase 3 BPH and Phase 2 Prostate Cancer Clinical Trial Activities 11:30 a.m. Jan. 28, 2014 - GlobeNewswire
Nymox Closes Recruitment for NX-1207 Phase 2 Prostate Cancer Trial 10:00 a.m. Jan. 13, 2014 - GlobeNewswire
Madison Capital Corporation Announces Proposed Qualifying Transaction 12:36 p.m. Nov. 21, 2013 - Marketwire
(0)
(0)